NLRP3 and cardiac hypertrophy: Specifically, SIRT1 activationfinally alleviates cardiac hypertrophy by inhibiting the ROS-induced TGF1/Sma and mad homolog 3 (Smad3)signaling pathway [100] and inhibiting NLRP3 inflammasome activation [101].